Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1995-8-17
|
pubmed:abstractText |
Effects of lithium on central 5-HT function have been shown using electrophysiological, behavioural and neurochemical approaches. Chronic lithium administration, for example, enhances both electrophysiological and behavioural responses mediated by postsynaptic 5-HT1A receptors as well as increasing potassium-evoked and electrically evoked release of 5-HT from the hippocampus in in vitro slices and in vivo. Our studies have shown that potassium-channel blocking drugs increase 5-HT release in vivo, and others have shown that lithium suppresses potassium currents in some cell types. We therefore investigated in the rat the effect of short-term (3 days) and long-term (21 days) lithium on 5-HT release evoked by potassium-channel blockade, using in vivo microdialysis. Long-term lithium treatment enhanced 5-HT efflux in rat hippocampus produced by 4-aminopyridine (4-AP) perfused in microdialysis fluid by as much as 100% within 40 min, compared with non-lithium-treated control rats. Short-term lithium treatment did not enhance 4-AP-induced 5-HT efflux. The effect of local tetraethylammonium chloride (TEA) on hippocampal 5-HT release was unaltered by long-term lithium treatment. In addition, neither the effect of local perfusion with 4-AP on efflux of striatal 5-HT, or dopamine in nucleus accumbens, was altered by chronic lithium treatment. These results show that long-term lithium treatment enhances 4-AP-stimulated efflux of 5-HT in the hippocampus, but not in the striatum, nor dopamine output in the nucleus accumbens.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/4-Aminopyridine,
http://linkedlifedata.com/resource/pubmed/chemical/Lithium,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channel Blockers,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin,
http://linkedlifedata.com/resource/pubmed/chemical/Tetraethylammonium,
http://linkedlifedata.com/resource/pubmed/chemical/Tetraethylammonium Compounds
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0959-4965
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
716-20
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7605933-4-Aminopyridine,
pubmed-meshheading:7605933-Animals,
pubmed-meshheading:7605933-Corpus Striatum,
pubmed-meshheading:7605933-Dopamine,
pubmed-meshheading:7605933-Drug Synergism,
pubmed-meshheading:7605933-Hippocampus,
pubmed-meshheading:7605933-Lithium,
pubmed-meshheading:7605933-Male,
pubmed-meshheading:7605933-Nucleus Accumbens,
pubmed-meshheading:7605933-Potassium Channel Blockers,
pubmed-meshheading:7605933-Rats,
pubmed-meshheading:7605933-Rats, Sprague-Dawley,
pubmed-meshheading:7605933-Serotonin,
pubmed-meshheading:7605933-Tetraethylammonium,
pubmed-meshheading:7605933-Tetraethylammonium Compounds,
pubmed-meshheading:7605933-Time Factors
|
pubmed:year |
1995
|
pubmed:articleTitle |
5-HT efflux from rat hippocampus in vivo produced by 4-aminopyridine is increased by chronic lithium administration.
|
pubmed:affiliation |
Oxford University SmithKline Beecham Centre for Applied Neuropsychobiology, UK.
|
pubmed:publicationType |
Journal Article
|